• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4646951)   Today's Articles (3928)   Subscriber (50671)
For: Liang JY, Tong F, Gu FF, Liu YY, Zeng YL, Hong XH, Zhang K, Liu L. Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report. Medicine (Baltimore) 2017;96:e6985. [PMID: 28538405 PMCID: PMC5457885 DOI: 10.1097/md.0000000000006985] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
Number Cited by Other Article(s)
1
Park HY, Kwon MJ, Kang HS, Kim YJ, Kim NY, Kim MJ, Min KW, Choi KC, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Choe JY, Lee HK. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets. Hum Pathol 2019;87:83-94. [DOI: 10.1016/j.humpath.2019.02.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Revised: 02/22/2019] [Accepted: 02/24/2019] [Indexed: 01/07/2023]
2
Erratum: Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum. Medicine (Baltimore) 2017;96:e7644. [PMID: 31305693 PMCID: PMC5521951 DOI: 10.1097/md.0000000000007644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA